Artificial Intelligence Transforms How UF Researchers Forecast and Respond to Disease
Because UF is home to the HiPerGator and has driven its AI initiative to expand faculty expertise, AI is transforming how they do research in fighting diseases such as anthrax, HIV, COVID-19, and more.
Camera in Space to Capture the Impossible
Satlantis has been developing a camera to photograph the universe's dark matter -- which, by the way, is invisible.
Tech Tuesday: UF Researcher Showcases New Technology That Alerts Patients Healing From Surgery When They May Need to Relax
“What if smart technology could be used to improve at-home care for orthopedic patients? We’re here at UF’s Malachowsky Hall to find out more. Dr. Bhunia, tell us more about where we are,” said Bethany Gaffey, host of UF Innovate.
First Type 1 Diabetes Patient Enrolled in Rise Therapeutics’ Latest Clinical Trial
Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, announced it has enrolled its first patient in its R-5280 placebo-controlled, blinded, Phase 1b type 1 diabetes clinical trial.
A Living Library: Rare Collection at UF Drives Breakthroughs in Biomedical Discovery
Compiled over the course of 80 years, some of the organisms in this living library collection’s glass vials are likely extinct in the natural world, offering an irreplaceable window into the past. For Ben Shen, PhD, a professor of chemistry and director of the Natural Products Discovery Center, and his research team at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Jupiter, Florida, these unexplored microbes — a treasure trove of biodiversity — hold untold promise for treating disease, providing a tantalizing glimpse into the future of drug discovery.
JPMorgan Upgrades Solid Biosciences Stock, Sees Growth Potential
JPMorgan upgraded Solid Biosciences stock, a biotechnology company that acquired UF startup AavantiBio, from Neutral to Overweight, and increased the price target to $15.00 from the previous $10.00. The firm's decision reflects a positive outlook on the company's prospects, particularly with upcoming developments expected in the fourth quarter.
Dr. Read Hayes of the LPRC Is Recognized as a Global Thought Leader
The Life Safety Alliance (LSA), an organization dedicated to enhancing global life safety and security through partnerships and collaborations, has announced the results of its Top 40 Global Thought Leaders in Security and Life Safety. UF Innovate | Accelerate client Loss Prevention Research Council's Read Hayes is recognized as a global thought leader.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
UF startup Cannabix Technologies Inc. reports that early testing by Omega Laboratories Inc. with Cannabix's marijuana breathalyzer technology has garnered positive results.
How AI Will Transform the Olympics
University of Florida experts say the artificial intelligence revolution will soon bring some of the biggest changes the international competition has seen in its 128-year history.
Kriya Appoints Scientific Co-Founder J. Fraser Wright, Ph.D., as Chief Gene Therapy Officer
UF startup Kriya Therapeutics, Inc., a biopharmaceutical company developing gene therapies to address common diseases affecting millions of people around the world, announced the appointment of J. Fraser Wright, Ph.D., to the position of chief gene therapy officer.